Literature DB >> 19478714

Decrease in serum levels of advanced glycation end-products by short-term lifestyle modification in non-diabetic middle-aged females.

Takahiro Yoshikawa1, Aiko Miyazaki, Shigeo Fujimoto.   

Abstract

BACKGROUND: Advanced glycation end products (AGEs) play an important role in development of atherosclerosis in diabetes and uremic diseases. However, there is currently little information available on the effects of lifestyle modification on circulating AGEs in subjects without these diseases. MATERIAL/
METHODS: Serum levels of Nepsilon-(carboxymethyl) lysine (CML), pentosidine, derivatives of reactive oxygen metabolites (d-ROMs), adipokines, and renal function were determined in forty-seven middle-aged females. Among them, seventeen participated in a 12-week lifestyle modification (LM) program and twelve age-matched subjects were assigned to a control group. The LM program consisted of an initial educational session and encouragement.
RESULTS: At baseline, serum HDL-cholesterol was correlated with CML level (P=0.003), whereas body fat mass (P=0.012) and fat consumption (P=0.007) were correlated with pentosidine levels. After intervention, significant reductions were observed in the LM group in body fat, serum HDL-cholesterol, CML, and pentosidine. Of note, in the LM group, average number of steps in daily walking was significantly correlated with decrease in CML level (P=0.044). Decrease in pentosidine level exhibited significant positive correlations with reduction in body weight (P=0.007) and body fat mass (P=0.038).
CONCLUSIONS: The present findings suggest lifestyle modification as a promising approach to reducing circulating AGE levels even in healthy middle-aged females with neither overt diabetes nor renal dysfunction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19478714

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  18 in total

1.  Life-long endurance running is associated with reduced glycation and mechanical stress in connective tissue.

Authors:  Christian Couppé; René B Svensson; Jean-Francois Grosset; Vuokko Kovanen; Rie H Nielsen; Morten R Olsen; Jytte O Larsen; Stephan F E Praet; Dorthe Skovgaard; Mette Hansen; Per Aagaard; Michael Kjaer; S Peter Magnusson
Journal:  Age (Dordr)       Date:  2014-07-05

2.  Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial.

Authors:  Richard D Semba; Sarah K Gebauer; David J Baer; Kai Sun; Randi Turner; Harry A Silber; Sameera Talegawkar; Luigi Ferrucci; Janet A Novotny
Journal:  J Nutr       Date:  2014-04-17       Impact factor: 4.798

Review 3.  Dietary Advanced Glycation End Products and Cardiometabolic Risk.

Authors:  Claudia Luévano-Contreras; Armando Gómez-Ojeda; Maciste Habacuc Macías-Cervantes; Ma Eugenia Garay-Sevilla
Journal:  Curr Diab Rep       Date:  2017-08       Impact factor: 4.810

Review 4.  Advanced glycation end-products: a biological consequence of lifestyle contributing to cancer disparity.

Authors:  David P Turner
Journal:  Cancer Res       Date:  2015-04-28       Impact factor: 12.701

5.  Dietary advanced glycation end products and the risk of postmenopausal breast cancer in the National Institutes of Health-AARP Diet and Health Study.

Authors:  Lindsay L Peterson; Seho Park; Yikyung Park; Graham A Colditz; Narges Anbardar; David P Turner
Journal:  Cancer       Date:  2020-02-25       Impact factor: 6.860

6.  AGE metabolites: a biomarker linked to cancer disparity?

Authors:  Dion Foster; Laura Spruill; Katherine R Walter; Lourdes M Nogueira; Hleb Fedarovich; Ryan Y Turner; Mahtabuddin Ahmed; Judith D Salley; Marvella E Ford; Victoria J Findlay; David P Turner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-22       Impact factor: 4.254

Review 7.  The Role of Advanced Glycation End-Products in Cancer Disparity.

Authors:  D P Turner
Journal:  Adv Cancer Res       Date:  2016-10-12       Impact factor: 5.767

Review 8.  Dietary advanced glycation end products and aging.

Authors:  Claudia Luevano-Contreras; Karen Chapman-Novakofski
Journal:  Nutrients       Date:  2010-12-13       Impact factor: 5.717

9.  Influence of Physical Activity Intervention on Circulating Soluble Receptor for Advanced Glycation end Products in Elderly Subjects.

Authors:  Kazuhiko Kotani; Russell Caccavello; Naoki Sakane; Toshiyuki Yamada; Nobuyuki Taniguchi; Alejandro Gugliucci
Journal:  J Clin Med Res       Date:  2011-09-26

10.  Examination of the Effectiveness of the Healthy Empowered Active Lifestyles (HEAL) Program on Advanced Glycation End Products.

Authors:  Mathew J Gregoski; Janis Newton; Kathleen Blaylock; Sheila A O Smith; David P Turner
Journal:  Int J Environ Res Public Health       Date:  2021-05-02       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.